First Monday
Jobs
Jobs open to youOnly jobs that can hire where you liveA CV for each jobWritten from your record, every line checkedMemoryIt remembers, so you don’t repeat yourselfInterview helpResearch, prep and hints only you seeWatch how it works0:28
FAQDocsUse in AI, Free
Your countryNorth AmericaEuropeAsia-PacificLatin AmericaNot on the list? Tell us where you liveRequest early accessEarly access
First Monday

Remote jobs that can actually hire you.

One email to confirm your address, and another when your group is invited. Free during the beta. By requesting access you agree to the Terms & Conditions and the Privacy Policy.

Beta formacOSWindows

Jobs

Jobs open to you in CanadaRemote jobs in the USRemote jobs in PolandRemote jobs in the UKRemote jobs in CanadaRemote jobs in Mexico

Product

Jobs open to youA CV for each jobMemoryInterview helpHow it works

Company

FAQContact

Legal

Privacy PolicyTerms & Conditions
Jobs
Jobs open to you in CanadaRemote jobs in the USRemote jobs in PolandRemote jobs in the UKRemote jobs in CanadaRemote jobs in Mexico
Product
Jobs open to youA CV for each jobMemoryInterview helpHow it works
Company
FAQContact
Legal
Privacy PolicyTerms & Conditions
Remote jobs by country
United StatesPolandUnited KingdomCanadaMexicoBrazilGermanySpainPortugalIrelandNetherlandsIndiaSwedenBelgiumAustriaDenmarkFinlandSwitzerlandNorwayAustraliaNew Zealand

Remote jobs by country

United StatesPolandUnited KingdomCanadaMexicoBrazilGermanySpainPortugalIrelandNetherlandsIndiaSwedenBelgiumAustriaDenmarkFinlandSwitzerlandNorwayAustraliaNew Zealand
© 2026 First MondayNo tracking cookies. Anonymous page statistics only.
First Monday
Jobs/Healthcare/Healthcare Policy Lobbyist (Biotech)

Healthcare Policy Lobbyist (Biotech)

EQL Tech

San Francisco, California, United States…HealthcarePosted July 17, 2026
Probably open to people in the United StatesApply for this job Write my CV for this job Early access
Pay
$200,000–$250,000 a year
Required
biotech, life sciences, FDA / clinical-trial policy
Nice to have
PDUFA, user-fee reauthorizations, FDA review-pathway reform
Benefits
Health insurance, Paid time off, Learning budget
Posted
July 17, 2026
Company
EQL Tech

Who it can hire

We read the post for each of the 21 countries we cover.

  • Probably open to people in the US · Only some regions

    The listing’s location: “San Francisco, California, United States · Washington, District of Columbia, United States · Boston, Massachusetts, United States · New York, United States”.

  • Not open to people in the other 20 countries we cover, as far as the post says.

The job post

About the initiative

Clinical trials in the United States take too long, cost too much, and are too tangled in outdated rules — and the country develops far fewer of the therapies it could. The Clinical Trial Abundance Initiative exists to change that at the root: by reforming the federal policy and law that govern how trials are run, so that high-quality trials become dramatically faster, cheaper, and simpler to conduct.

We are a new, founder-led effort backed by a coalition of leading science philanthropies. The 2027 reauthorization of the Prescription Drug User Fee Act (PDUFA) is a rare, high-leverage window to move real reform — and we are building both the organization and the coalition to make the most of it, and to sustain momentum well beyond it. We draw on what already works abroad, from Australia's notification-based trial pathway to reforms across the UK and elsewhere.

What this role is — and isn't

This is a policy and law reform role, not an operations or access role. The work is to change the rules — the federal policy and law governing clinical trials — so that more trials can be launched, run, and approved, faster and at lower cost.

To be direct about scope: you will not be operating or running trials, and the role is not focused on trial access, diversity, inclusion, or equity. Those aims matter, but they are a different kind of work. This role exists to make trials themselves faster, cheaper, and more abundant to conduct — by reforming the system that governs them.

The role

This is a founding leadership role, working in close partnership with the initiative's Chief Science Officer to build the effort from the ground up. It runs on two horizons at once.

In the near term, you are the initiative's credible face in policy — the person who can sit across from a Senate HELP or House Energy & Commerce staffer, an FDA official, a hospital system's leadership, or a biotech CEO, and be taken seriously by all of them. You help shape the legislative and regulatory reform agenda and drive it into the PDUFA 2027 window and its implementation.

Over the medium term, you build the field. There is no standing constituency for clinical trial abundance today; your job is to create one — a durable, formidable coalition of companies, investors, researchers, patient organizations, and policymakers who will carry this work long after any single legislative moment.

What you'll do

  • Serve as the initiative's lead voice with legislators, congressional staff, and agency officials, and with health-system and industry leaders — building credibility and trust across a wide and varied set of stakeholders
  • Shape a substantive agenda to reform the policy and law around the cost, speed, and complexity of trials, and drive it into the PDUFA 2027 reauthorization and its implementation
  • Design and build the coalition — recruiting and aligning companies, investors, research and patient organizations, and allied policymakers into a lasting interest group
  • Translate the scientific and regulatory case for reform into arguments that move different audiences, in partnership with the Chief Science Officer
  • Set the initiative's strategy for the years beyond 2027, when the work is field-building rather than chasing a single deadline

Requirements

Who you are

  • Deep credibility in biotech, life sciences, or FDA / clinical-trial policy — this is a subject-matter role, not a generalist government-affairs one
  • A track record of being taken seriously by senior, varied stakeholders: Hill offices, agencies, industry executives, investors, and researchers alike
  • Evidence that you can build something durable, not only win a near-term legislative fight — coalition-building, institution-building, or genuine 0→1 experience
  • Fluent in the case for reform that expands what's possible — cutting the friction, cost, and time between good science and the patients who need it

Nice to have

  • Direct experience with PDUFA, user-fee reauthorizations, or FDA review-pathway reform
  • Familiarity with international regulatory models (Australia, UK, EU)
  • An existing network spanning biotech, investors, research, and DC policy

Benefits

  • Competitive salary of 200000-250000 USD/year
  • Private Health Insurance
  • Paid Time Off
  • Work From Home
  • Training & Development

First Monday isn’t the employer or a recruiter and isn’t affiliated with EQL Tech. Details may have changed since; confirm with the employer before you apply.

Probably open to people in the United StatesApply for this job Write my CV for this job Early access
Pay
$200,000–$250,000 a year
Required
biotech, life sciences, FDA / clinical-trial policy
Nice to have
PDUFA, user-fee reauthorizations, FDA review-pathway reform
Benefits
Health insurance, Paid time off, Learning budget
Posted
July 17, 2026
Company
EQL Tech

Similar jobs open to people in the United States

Principal, Clinical Program DevelopmentHeadway · Remote · USFeasibility Specialistworldwide · England, United Kingdom · Sofia…Clinical Quality ConsultantBayesian Health · Remote · USU.S. Regulatory Strategists (Senior Regulatory Affairs Associate/Consultant)Parexel · Remote · US
First Monday

Get jobs like this every Monday.

One email a week with new remote jobs open to people in Canada. Free, and one click to unsubscribe. Privacy Policy

Or request early access to the app
Apply for this job